Abstract:The frequency and risk factors for the development of diastolic dysfunction (DD) in patients with CPPD and OA have not been studied. The objective of this study was to determine the frequency and identify risk factors (RF) for the development of DD of the left and right ventricles (LV and RV) in patients with calcium pyrophosphate crystal deposition disease (CPPD) and osteoarthritis (OA). The study included 26 patients with CPPD and with knee OA 18–65 years old, matched in age and gender, without cardiovascular disease (CVD), type 2 diabetes mellitus (DM2), and rheumatic diseases. Conventional risk factors (TRF) of CVD were assessed, and echocardiography was performed. The frequency of DD in patients with CPPD and OA was quite high and almost did not differ in both groups: it was detected in 19 patients, of which 11 (42%) had CPPD and 8 (31%) had OA ( p = 0.39). Type 1 LV DD was detected in 10 (39%) patients with CPPD and in 8 (31%) with OA ( p = 0.11); type 1RV DD was detected in 8 (31%) patients with CPPD and in 7 (27%) patients with OA ( p = 0.17); and type 1 LV DD and RV DD was detected in 7 (27%) patients with both CPPD and with OA. DD types 2 and 3 were not detected in both groups. There were no differences in both groups in CV risk factors, except for the level of CRP (it was higher in CPPD) ( p = 0.03). In the CPPD group, mean values of LV E/E' ( p = 0.02), LVDT ( p = 0.03), LVMI ( p = 0.04) were significantly higher than in patients with OA. On the contrary, in patients with OA, indices EDV ( p = 0.004) and TVC ( p = 0.02) were higher. There were direct correlations between diastolic function indices and the following factors in CPPD: LVL, PWLV and PTH level ( r = 0.7, p <0.005), LV E' and PTH level ( r = 0.7, p < 0.005). Inverse correlations were found between the level of PTH and IS ( r = –0.5, p < 0.005), LVMI ( r = –0.5, p < 0.005), and the level of vitamin D and VDDT ( r = –0.6, p < 0.005). Direct correlations in OA were found between the level of CRP and PVAdiast ( r = 0.6, p < 0.005), and the level of sUA ( r = 0.7, p < 0.005), and the level of vitamin D and E/E'LV ( r = 0.6, p < 0.005). A high prevalence of LV and RV DD was found in patients with CPPD and OA. The presence of DD in CPPD was associated with lower vitamin D levels, and in OA with a higher level of sUA and a lower level of PTH.

Fractures in Patients with Acute CPP Crystal Arthritis Versus Matched Comparators in a Large Cohort Study

The Significance of Intracellular Versus Extracellular Calcium Pyrophosphate Crystals in Diagnosing Calcium Pyrophosphate Crystal Arthritis

The association between fracture and short-term adverse health outcomes among children with cerebral palsy

Features Associated With Different Inflammatory Phenotypes of Calcium Pyrophosphate Deposition Disease: Study Using Data From the International American College of Rheumatology/EULAR Calcium Pyrophosphate Deposition Classification Criteria Cohort

Acute coronary syndrome in calcium pyrophosphate deposition disease patients: A US inpatient care cohort study

Risk of Non-Vertebral Fracture in Gout Compared to Rheumatoid Arthritis

Relative Risk of Knee Chondrocalcinosis in Siblings of Index Cases with Pyrophosphate Arthropathy

Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort

Systematic review and quality analysis of emerging diagnostic measures for calcium pyrophosphate crystal deposition disease

C-reactive protein and fracture risk: European prospective investigation into Cancer Norfolk Study

Recent advances in the therapeutic management of calcium pyrophosphate deposition disease

Clinical characteristics and medical imaging analysis of 20 cases with calcium pyrophosphate deposition

Incidence of and risk of mortality after hip fractures in Rheumatoid Arthritis relative to the general population

Diastolic Dysfunction of the Left and Right Ventricles in Patients with Calcium Pyrophosphate Crystal Storage Disease and Osteoarthritis

Two cases of pressure ulcers related to acute calcium pyrophosphate crystal arthritis: A new concept of “disease‐specific unexpected external forces”

Progression of arthritis after four-corner fusion in patients with calcium pyrophosphate deposition disease: a case series of eleven patients

[Update on Gout and Calcium pyrophosphate deposition (CPPD)]

Risk Factor Analysis of Fragility Fractures in Rheumatoid Arthritis: A 3-Year Longitudinal, Real-World, Observational, Cohort Study

Bone health assessment in clinical practice is infrequenty performed in patients with chronic pancreatitis

Bone Mineral Density, Osteoporosis, and Fracture Risk in Adult Patients with Psoriasis or Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Observational Studies

Cartilage icing and chondrocalcinosis on knee radiographs in the differentiation between gout and calcium pyrophosphate deposition